Treatment of myelodysplastic syndromes with exogenous erythropoietin: a new therapeutic paradigm.
Mundle
S D
SD
Raza
A
A
D004920:Erythropoiesis; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000503:physiopathology; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin